CeriBell, Inc (CBLL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, CeriBell, Inc (CBLL) has a cash flow conversion efficiency ratio of -0.137x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-19.30 Million) by net assets ($140.81 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CeriBell, Inc (CBLL) defensive interval to measure how many days the company can operate on defensive assets alone.
CeriBell, Inc - Cash Flow Conversion Efficiency Trend (2022–2025)
This chart illustrates how CeriBell, Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
CeriBell, Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CeriBell, Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
YIDU TECH INC. DL -00002
F:0EL
|
N/A |
|
Sinoma Energy Conservation Ltd
SHG:603126
|
-0.039x |
|
Washington Trust Bancorp Inc
NASDAQ:WASH
|
0.041x |
|
Amsterdam Commodities NV
AS:ACOMO
|
-0.097x |
|
Zhejiang Jindun Fans Co Ltd
SHE:300411
|
0.000x |
|
Oculis Holding AG Ordinary shares
NASDAQ:OCS
|
-0.081x |
|
TSEC Corp
TW:6443
|
0.010x |
|
Akfen Yenilenebilir Enerji A.S.
IS:AKFYE
|
0.050x |
Annual Cash Flow Conversion Efficiency for CeriBell, Inc (2022–2025)
The table below shows the annual cash flow conversion efficiency of CeriBell, Inc from 2022 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of CeriBell, Inc.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $155.34 Million | $-40.81 Million | -0.263x | -43.31% |
| 2024-12-31 | $191.16 Million | $-35.04 Million | -0.183x | -170.57% |
| 2023-12-31 | $-112.25 Million | $-29.16 Million | 0.260x | -29.87% |
| 2022-12-31 | $-86.40 Million | $-32.00 Million | 0.370x | -- |
About CeriBell, Inc
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly t… Read more